Nihon Kohden acquires 71.4% stake in Ad-Tech Medical Instrument Corporation

Nihon Kohden announced the acquisition of a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation, a provider of specialized electrodes for epilepsy treatment and neurodiagnostic procedures. The deal strengthens Nihon Kohden's position in neurological diagnostics.

“Nihon Kohden, a global leader in medical device innovation for high-precision patient monitoring and diagnostics, today announced the acquisition of a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation.”businesswire.com

• 4 sources
• businesswire.comNihon Kohden Enhances Neurological Treatment Through the Acquisition of Ad-Tech Medical Instrument CorporationMedia ContactsNov 12, 2024
• medicaldevice-network.comNihon Kohden expands neurology portfolio with Ad-Tech Medical acquisitionPhalguni DeswalNov 13, 2024
• latimes.comAd-Tech Medical Instrument Corporation Acquired by Nihon Kohden - Los Angeles TimesNov. 13, 2024 11 AM PTNov 13, 2024
• archimed.groupARCHIMED earns 5x selling a majority of Ad-TechNov 26, 2024

Summarized from public sources; check the original articles before acting on it.